Expression of each target was evaluated in separate sets of dual ISH/ICC experiments presented in Fig 3: panel A shows CD69 dual ISH/ICC, panel B shows Notch1 dual ISH/ICC. The gene discussed is CD69; the disease is intrahepatic cholangiocarcinoma.